Patients with inflammatory bowel disease (IBD) are at increased risk for developing opportunistic infections due to factors that include receiving immunosuppressive and immunomodulatory therapy [particularly anti-tumor necrosis factor-α (anti-TNF-α) agents], severity of disease, and malnutrition [7–10]. Here, TNF is linked to Opportunistic infection.